A recall of four repackaged lots of blood pressure medicine expanded on Wednesday.
According to the U.S. Food and Drug Administration (FDA), Legacy Pharmaceutical Packaging, LLC has recalled four lots of Losartan Tablet USP 50 mg because of a detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA).
The four repackaged lots numbers are: 180190, 180191, 181597, 181598. They can be identified on the bottles.
The company has not received any reports of adverse events related to this recall.
Officials say consumers should contact their physician or healthcare provider if they have questions related to taking this drug.